Despite the clinical progress of anti-HER2 targeted therapies and anti-PD-1/PD-L1 immunotherapies (Bang et al, 2010; Janjigian et al, 2021; Kang et al, 2017), specific and effective treatment strategies for GC are still lacking. The gene discussed is CD274; the disease is gastric cancer.